Walkner Condon Financial Advisors LLC Gilead Sciences, Inc. Transaction History
Walkner Condon Financial Advisors LLC
- $459 Million
- Q2 2024
A detailed history of Walkner Condon Financial Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Walkner Condon Financial Advisors LLC holds 3,110 shares of GILD stock, worth $244,819. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,110
Previous 3,110
-0.0%
Holding current value
$244,819
Previous $213,000
-0.0%
% of portfolio
0.05%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
1,879Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$9.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.07 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$4.76 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.67 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $98.7B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...